Genomic Aberrations Associated with the Pathophysiological Mechanisms of Neurodevelopmental Disorders
Open Access
- 4 September 2021
- Vol. 10 (9), 2317
- https://doi.org/10.3390/cells10092317
Abstract
Genomic studies are increasingly revealing that neurodevelopmental disorders are caused by underlying genomic alterations. Chromosomal microarray testing has been used to reliably detect minute changes in genomic copy numbers. The genes located in the aberrated regions identified in patients with neurodevelopmental disorders may be associated with the phenotypic features. In such cases, haploinsufficiency is considered to be the mechanism, when the deletion of a gene is related to neurodevelopmental delay. The loss-of-function mutation in such genes may be evaluated using next-generation sequencing. On the other hand, the patients with increased copy numbers of the genes may exhibit different clinical symptoms compared to those with loss-of-function mutation in the genes. In such cases, the additional copies of the genes are considered to have a dominant negative effect, inducing cell stress. In other cases, not the copy number changes, but mutations of the genes are responsible for causing the clinical symptoms. This can be explained by the dominant negative effects of the gene mutations. Currently, the diagnostic yield of genomic alterations using comprehensive analysis is less than 50%, indicating the existence of more subtle alterations or genomic changes in the untranslated regions. Copy-neutral inversions and insertions may be related. Hence, better analytical algorithms specialized for the detection of such alterations are required for higher diagnostic yields.Funding Information
- Japan Society for the Promotion of Science (JSPS KAKENHI JP18K07803)
This publication has 49 references indexed in Scilit:
- Loss-of-function mutation of collybistin is responsible for X-linked mental retardation associated with epilepsyJournal of Human Genetics, 2011
- A new microdeletion syndrome of 5q31.3 characterized by severe developmental delays, distinctive facial features, and delayed myelinationAmerican Journal of Medical Genetics Part A, 2011
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesAmerican Journal of Human Genetics, 2010
- Small Deletions of SATB2 Cause Some of the Clinical Features of the 2q33.1 Microdeletion SyndromePLOS ONE, 2009
- A de novo 1.9‐Mb interstitial deletion of 3q13.2q13.31 in a girl with dysmorphic features, muscle hypotonia, and developmental delayAmerican Journal of Medical Genetics Part A, 2009
- Array analysis and karyotyping: Workflow consequences based on a retrospective study of 36,325 patients with idiopathic developmental delay in the NetherlandsEuropean Journal of Medical Genetics, 2009
- Molecular mechanisms and diagnosis of chromosome 22q11.2 rearrangementsDevelopmental Disabilities Research Reviews, 2008
- Recurrent 16p11.2 microdeletions in autismHuman Molecular Genetics, 2007
- Heterozygous nonsense mutationSATB2 associated with cleft palate, osteoporosis, and cognitive defectsHuman Mutation, 2007
- A deep intronic mutation in the RB1 gene leads to intronic sequence exonisationEuropean Journal of Human Genetics, 2007